Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Walter L. Longo MD


Institution: Medical College of Wisconsin
Department: Medicine
Division: Hematology and Oncology - Medicine
Program: Hematology


  • VcR-CVAD Induction Chemotherapy Followed by Maintenance Rituximab Produces Durable Remissions in Mantle Cell Lymphoma: A Wisconsin Oncology Network Study. (Chang JE, Carmichael LL, Kim K, Peterson C, Yang DT, Traynor AM, Werndli JE, Huie MS, McFarland TA, Volk M, Blank J, Callander NS, Longo WL, Kahl BS) Clin Lymphoma Myeloma Leuk 2018 Jan;18(1):e61-e67 PMID: 29191715 PMCID: PMC5896779 12/02/2017    
  • Retrospective analysis of fluoroquinolone prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplantation. (Simondsen KA, Reed MP, Mably MS, Zhang Y, Longo WL) J Oncol Pharm Pract 2013 Dec;19(4):291-7 PMID: 23184539 11/28/2012       6 Citations
  • VcR-CVAD induction chemotherapy followed by maintenance rituximab in mantle cell lymphoma: a Wisconsin Oncology Network study. (Chang JE, Peterson C, Choi S, Eickhoff JC, Kim K, Yang DT, Gilbert LA, Rogers ES, Werndli JE, Huie MS, McFarland TA, Volk M, Blank J, Callander NS, Longo WL, Kahl BS) Br J Haematol 2011 Oct;155(2):190-7 PMID: 21848883 PMCID: PMC3188692 08/19/2011       42 Citations
  • Rituximab and CHOP chemotherapy plus GM-CSF for previously untreated diffuse large B-cell lymphoma in the elderly: a Wisconsin oncology network study. (Chang JE, Seo S, Kim KM, Werndli JE, Bottner WA, Rodrigues GA, Sanchez FA, Saphner TJ, Longo WL, Kahl BS) Clin Lymphoma Myeloma Leuk 2010 Oct;10(5):379-84 PMID: 21030351 PMCID: PMC3360541 10/30/2010       6 Citations
  • Augmented and standard Berlin-Frankfurt-Munster chemotherapy for treatment of adult acute lymphoblastic leukemia. (Chang JE, Medlin SC, Kahl BS, Longo WL, Williams EC, Lionberger J, Kim K, Kim J, Esterberg E, Juckett MB) Leuk Lymphoma 2008 Dec;49(12):2298-307 PMID: 19052977 PMCID: PMC2844086 12/05/2008       21 Citations
  • F-18 FDG PET imaging of GVHD-associated polymyositis. (Agriantonis DJ, Perlman SB, Longo WL) Clin Nucl Med 2008 Oct;33(10):688-9 PMID: 18806568 09/23/2008    
  • Thalidomide maintenance following high-dose melphalan with autologous stem cell support in myeloma. (Chang JE, Juckett MB, Callander NS, Kahl BS, Gangnon RE, Mitchell TL, Longo WL) Clin Lymphoma Myeloma 2008 Jun;8(3):153-8 PMID: 18650178 PMCID: PMC2913594 07/25/2008       5 Citations
  • A 5-drug regimen maximizing the dose of cyclophosphamide is effective therapy for adult Burkitt or Burkitt-like lymphomas. (Kujawski LA, Longo WL, Williams EC, Turman NJ, Brandt N, Mosher DF, Eickhoff JC, Kahl BS) Cancer Invest 2007 Mar;25(2):87-93 PMID: 17453819 04/25/2007       7 Citations
  • Pathophysiology and management of fever revisited. (Robins HI, Brandt K, Longo WL) J Support Oncol 2006 Jun;4(6):265-6; author reply 266 PMID: 16805328 06/30/2006       1 Citations
  • Maintenance rituximab following induction chemoimmunotherapy may prolong progression-free survival in mantle cell lymphoma: a pilot study from the Wisconsin Oncology Network. (Kahl BS, Longo WL, Eickhoff JC, Zehnder J, Jones C, Blank J, McFarland T, Bottner W, Rezazedeh H, Werndli J, Bailey HH, Wisconsin Oncology Network) Ann Oncol 2006 Sep;17(9):1418-23 PMID: 16766582 06/13/2006       86 Citations
  • Excessive toxicity of the high dose thiotepa and etoposide regimen when combined with radiation: Long-term autologous transplantation experience in follicular and mantle cell lymphoma. (Fenske TS, Kahl BS, Eickhoff J, Mitchell TL, Smith EP, Atkinson E, McCoy AG, Eckstein L, Flynn B, McMannes J, Howard S, Longo WL) Leuk Lymphoma 2005 Oct;46(10):1441-8 PMID: 16194889 10/01/2005       6 Citations
  • Phase II study of weekly low-dose paclitaxel for relapsed and refractory non-Hodgkin's lymphoma: a Wisconsin Oncology Network Study. (Kahl BS, Bailey HH, Smith EP, Turman N, Smith J, Werndli J, Williams EC, Longo WL, Kim KM, McGovern J, Jumonville A) Cancer Invest 2005;23(1):13-8 PMID: 15779863 03/23/2005       13 Citations
  • A novel preparative regimen for autologous transplant in non-Hodgkin's lymphoma: long-term experience with etoposide and thiotepa. (McCoy AG, Smith EP, Atkinson ME, Baranski B, Kahl BS, Juckett M, Mitchell T, Gangnon R, Longo WL) Bone Marrow Transplant 2004 Jan;33(1):19-24 PMID: 14704653 01/06/2004       5 Citations
  • Fludarabine and cytarabine as a sequential infusion regimen for treatment of adults with recurrent, refractory or poor prognosis acute leukemia. (Vidarsson B, Abonour R, Williams EC, Woodson RD, Turman NJ, Kim K, Mosher DF, Wiersma SR, Longo WL) Leuk Lymphoma 2001 Apr;41(3-4):321-31 PMID: 11378544 05/30/2001       18 Citations
  • Addition of high-dose Ara-C to the BMT conditioning regimen reduces leukemia relapse without an increase in toxicity. (Mineishi S, Longo WL, Atkinson ME, Smith EP, Hamielec M, Wiersma SR, Kinsella TJ, Schuening FG) Bone Marrow Transplant 1999 Jun;23(12):1217-22 PMID: 10414906 07/22/1999       19 Citations
  • Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation. (Ratanatharathorn V, Nash RA, Przepiorka D, Devine SM, Klein JL, Weisdorf D, Fay JW, Nademanee A, Antin JH, Christiansen NP, van der Jagt R, Herzig RH, Litzow MR, Wolff SN, Longo WL, Petersen FB, Karanes C, Avalos B, Storb R, Buell DN, Maher RM, Fitzsimmons WE, Wingard JR) Blood 1998 Oct 01;92(7):2303-14 PMID: 9746768 09/25/1998       377 Citations
  • Acute tumor lysis syndrome and treatment response in patients treated for refractory chronic lymphocytic leukemia with short-course, high-dose cytosine arabinoside, cisplatin, and etoposide. (McCroskey RD, Mosher DF, Spencer CD, Prendergast E, Longo WL) Cancer 1990 Jul 15;66(2):246-50 PMID: 2369709 07/15/1990       35 Citations
  • Adjunctive therapy (whole body hyperthermia versus lonidamine) to total body irradiation for the treatment of favorable B-cell neoplasms: a report of two pilot clinical trials and laboratory investigations. (Robins HI, Longo WL, Steeves RA, Cohen JD, Schmitt CL, Neville AJ, O'Keefe S, Lagoni R, Riggs C) Int J Radiat Oncol Biol Phys 1990 Apr;18(4):909-20 PMID: 2182581 04/01/1990       25 Citations
  • Phase I trial of lonidamine with whole body hyperthermia in advanced cancer. (Robins HI, Longo WL, Lagoni RK, Neville AJ, Hugander A, Schmitt CL, Riggs C) Cancer Res 1988 Nov 15;48(22):6587-92 PMID: 3180069 11/15/1988       27 Citations
  • A pilot study of whole body hyperthermia and local irradiation for advanced non-small cell lung cancer confined to the thorax. (Robins HI, Longo WL, Steeves RA, Lagoni RK, Hugander A, Neville AJ, O'Keefe S, Giese W, Schmitt CL) Int J Radiat Oncol Biol Phys 1988 Aug;15(2):427-31 PMID: 2841265 08/01/1988       12 Citations
  • Cytomegalovirus-associated tubulointerstitial nephritis in an allogeneic bone marrow transplant recipient. (Shorr RI, Longo WL, Oberley TD, Bozdech MJ, Walker DL) Ann Intern Med 1987 Sep;107(3):351-2 PMID: 3039888 09/01/1987    
  • Role of the spleen in the transdiaphragmatic spread of Hodgkin's disease. (Mann JL, Hafez GR, Longo WL) Am J Med 1986 Dec;81(6):959-61 PMID: 3799656 12/01/1986       1 Citations
  • Trusteeship: shared mission for religious and laity. (Longo WL) Hosp Prog 1981 Mar;62(3):58, 60 PMID: 10250125 02/10/1981    
  • Last update: 06/11/2018
    jenkins-FCD Prod-237 8f1a451f877a8b713cb0bc72324b845d75d9edf7